Show simple item record

dc.contributor.authorShakouri, A
dc.contributor.authorAdljouy, N
dc.contributor.authorBalkani, S
dc.contributor.authorMohamadi, M
dc.contributor.authorHamishehkar, H
dc.contributor.authorAbdolalizadeh, J
dc.contributor.authorKazem Shakouri, S
dc.date.accessioned2018-08-26T04:55:02Z
dc.date.available2018-08-26T04:55:02Z
dc.date.issued2018
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/38264
dc.description.abstractLeech saliva extract (LSE) in the liposome-based gel was used as a supplementary treatment to relief the signs and symptoms of osteoarthritis (OA). The saliva of medical leech was extracted and nano liposomes were used to formulate the supplement to enhance skin absorption. A clinical trial was designed to evaluate the therapeutic effects of LSE liposomal gel. Lenquesne and VAS questionnaires were used as indexes of this supplement therapy efficacy for 30 days. Questionnaires analysis showed that after one-month administration of LSE liposomal gel, patients' pain was relieved approximately up to 50%; also, due to reduction in joint inflammation and stiffness, the range of motion was increased and the patients' quality of life was enhanced (pآ <آ 0.001). LSE nano scaled liposomal gel as an innovative supplement therapy in OA patients, makes desirable therapeutic approach, which seems to make a significant impact on patient's quality of life and self-care capability.
dc.language.isoEnglish
dc.relation.ispartofComplementary therapies in clinical practice
dc.titleEffectiveness of topical gel of medical leech (Hirudo medicinalis) saliva extract on patients with knee osteoarthritis: A randomized clinical trial.
dc.typearticle
dc.citation.volume31
dc.citation.spage352
dc.citation.epage359
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.1016/j.ctcp.2017.12.001


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record